Wednesday - July 08, 2026

Category Archives: Science

Non-Alcoholic Fatty Liver Disease Pipeline Accelerates as 90+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “Non-Alcoholic Fatty Liver Disease Pipeline Insight 2026” report provides comprehensive insights about 90+ companies and 100+ pipeline drugs in the Non-Alcoholic Fatty Liver Disease pipeline landscape. It covers the Non Alcoholic Fatty Liver Disease pipeline drug profiles, including clinical … Continue reading →

Marginal Zone Lymphoma Pipeline Accelerates as 50+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “Marginal Zone Lymphoma Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Marginal Zone Lymphoma pipeline landscape. It covers the Marginal Zone Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Neuroblastoma Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “Neuroblastoma Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in the Neuroblastoma pipeline landscape. It covers the Neuroblastoma Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Neuroblastoma Pipeline … Continue reading →

Sjögren’s Disease Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Sjogren’s Syndrome Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Sjogren’s Syndrome pipeline landscape. It covers the Sjogren’s Syndrome pipeline drugs profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

HER2 Positive Breast Cancer Pipeline Accelerates as 50+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “HER2 Positive Breast Cancer Pipeline Insight, 2026” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in HER2 Positive Breast Cancer pipeline landscape. It covers the HER2 Positive Breast Cancer pipeline drug profiles, including clinical and nonclinical … Continue reading →

Chronic Refractory Gout (CRG) Market is Projected to Witness Significant Growth by 2036 Owing to the Launch of Novel Urate-Lowering Therapies and Rising Burden of Uncontrolled Gout | DelveInsight

The Chronic Refractory Gout (CRG) Market is growing due to the rising prevalence of chronic gout, uncontrolled hyperuricemia, and increasing demand for effective urate-lowering therapies. Growing awareness of treatment-resistant gout and the development of pipeline candidates such as NASP (SEL-212), … Continue reading →

Non-Cystic Fibrosis Bronchiectasis (NCFB) Market is Projected to Witness Robust Growth by 2036 Owing to the Launch of First-in-Class Disease-Modifying Therapies and Expanding Bronchiectasis Treatment

The Non-Cystic Fibrosis Bronchiectasis (NCFB) Market is growing due to the rising prevalence of chronic respiratory diseases, improved diagnosis through HRCT, increasing healthcare expenditure, and advancements in targeted therapies. The approval of BRINSUPRI (brensocatib) and promising pipeline candidates such as … Continue reading →

Invasive Fungal Infections Market is Projected to Witness Robust Growth by 2036 Owing to the Launch of Novel Broad-Spectrum Antifungal Therapies and Rising Burden of Drug-Resistant Fungal Infections |

The Invasive Fungal Infections (IFIs) Market is growing due to the rising incidence of opportunistic fungal infections in immunocompromised patients, increasing antifungal resistance, expanding organ transplantation, and growing cancer cases. Demand for advanced antifungal therapies is rising, while promising pipeline … Continue reading →

MacroAlga Expands Seaweed Extract Supply for Buyers Seeking Reliable Biostimulant Ingredients

Qingdao MacroAlga Co., Ltd MacroAlga supplies enzymatic Seaweed Extract for biostimulant, Seaweed Fertilizer and Fertilizer Additive applications. Its portfolio includes Ecklonia maxima Extract, Ascophyllum nodosum Extract, Alginate Oligosaccharide, Chitosan Oligosaccharide and Protein Hydrolysate, supported by species-specific brown algae sourcing, scalable … Continue reading →

Drug Discovery Services Market to Reach $27.23 Billion by 2030, Driven by Rising Outsourcing and Expanding Biopharma R&D Pipelines

Drug Discovery Services Market by Process (Target Validation, Hit-to-Lead, Lead Optimization), Type (Chemistry, Biology), Therapeutic Area (Oncology, Neurology, Infectious, CVD), Drug Type (Small Molecules, Biologics), End User – Global Forecast to 2030 According to MarketsandMarkets™, The global Drug Discovery Services … Continue reading →